Li Li

机构：The University of Texas MD Anderson Cancer Center, Army Medical University, Chongqing University, Shanxi Medical University, Shanghai Jiao Tong University, Xinqiao Hospital, Tongji Hospital, Shanxi Cardiovascular Hospital, S.P.E.C.I.E.S., Huazhong University of Science and Technology, Henan Medical University · ORCID：0000-0002-1421-7724

发表论文 126 篇 · 总被引 1714 次 · h-index 24

代表论文

• A novel mitochondria-related gene signature in esophageal carcinoma: prognostic, immune, and therapeutic features (2023 · Functional & Integrative Genomics · 被引 26)
• A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis (2023 · Blood Cancer Journal · 被引 23)
• Deciphering the temporal transcriptional landscape of human fetal leptomeninges (2024 · Brain · 被引 11)
• Paramagnetic susceptibility measured by magnetic resonance imaging as an in vivo biomarker for iron pathology in epilepsy (2025 · Science Advances · 被引 7)
• NUP98::Nsd1 and FLT3-ITD collaborate to generate acute myeloid leukemia (2023 · Leukemia · 被引 5)
• IL-32/NFκB/miR-205 loop sustains the high expression of IL-32 and enhances the motility of cervical cancer cells (2024 · Human Cell · 被引 4)